HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Robert G Ulrich Selected Research

staphylococcal enterotoxin B

1/2012Therapeutic inhibition of pro-inflammatory signaling and toxicity to staphylococcal enterotoxin B by a synthetic dimeric BB-loop mimetic of MyD88.
10/2011MyD88-dependent pro-inflammatory cytokine response contributes to lethal toxicity of staphylococcal enterotoxin B in mice.
1/2010Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.
1/2008Interleukin-15 increases vaccine efficacy through a mechanism linked to dendritic cell maturation and enhanced antibody titers.
4/2002Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Robert G Ulrich Research Topics

Disease

12Septic Shock (Toxic Shock Syndrome)
01/2012 - 04/2002
8Infection
01/2015 - 05/2002
7Anthrax
07/2011 - 01/2005
4Smallpox (Variola)
01/2015 - 10/2008
4Plague (Bubonic Plague)
05/2009 - 09/2004
2Fever (Fevers)
12/2014 - 04/2003
2Vaccinia
06/2014 - 10/2008
2Sepsis (Septicemia)
05/2009 - 01/2008
1Abscess
01/2015
1Lung Abscess
01/2015
1Necrosis
08/2010
1Communicable Diseases (Infectious Diseases)
01/2010
1Monkeypox
01/2010
1Botulism
01/2008
1Neoplasms (Cancer)
11/2003
1Venezuelan Equine Encephalomyelitis
04/2002

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)IBA
01/2015 - 09/2004
7VaccinesIBA
12/2014 - 04/2003
7AntigensIBA
02/2013 - 12/2006
6EnterotoxinsIBA
09/2011 - 04/2002
5ProteomeIBA
06/2014 - 10/2008
5staphylococcal enterotoxin BIBA
01/2012 - 04/2002
3Biological Markers (Surrogate Marker)IBA
01/2015 - 05/2009
3Immunoglobulin G (IgG)IBA
11/2013 - 01/2010
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2010 - 11/2003
3AntibodiesIBA
01/2010 - 10/2008
2Staphylococcal Protein A (A, Protein)IBA
06/2014 - 01/2010
2CytokinesIBA
09/2011 - 01/2011
2Interferon-alpha (Interferon Alfa)FDA Link
08/2010 - 11/2003
1ParaffinIBA
01/2015
1Formaldehyde (Formol)FDA Link
01/2015
1Phosphotransferases (Kinase)IBA
01/2015
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2015
1DryVax vaccineIBA
06/2014
1GalactosamineIBA
10/2011
1SiliconesIBA
07/2011
1abatacept (BELATACEPT)FDA Link
07/2011
1Interleukin-2 (IL2)IBA
08/2010
1Staphylococcal enterotoxin AIBA
08/2010
1Interleukin-1alpha (Interleukin 1 alpha)IBA
08/2010
1Interleukin-6 (Interleukin 6)IBA
08/2010
1Monoclonal AntibodiesIBA
01/2010
1Aluminum Hydroxide (Algeldrate)FDA Link
01/2008
1Combined VaccinesIBA
01/2008
1Streptococcus pyogenes SpeA proteinIBA
01/2008
1Interleukin-15 (Interleukin 15)IBA
01/2008
1Toll-Like Receptor 4IBA
11/2007
1Virulence Factors (Pathogenicity Factors)IBA
12/2006
1anthrax toxin (anthrax lethal factor)IBA
01/2005
1Toll-Like Receptors (Toll-Like Receptor)IBA
11/2003
1Interferon-gamma (Interferon, gamma)IBA
11/2003
1Double-Stranded RNA (RNA, Double Stranded)IBA
11/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2003

Therapy/Procedure

3Therapeutics
12/2014 - 03/2009
1Aftercare (After-Treatment)
08/2010
1Intranasal Administration
05/2007
1Mucosal Administration
01/2005